跳至主要内容
临床试验/JPRN-C000000372
JPRN-C000000372已完成3 期

Randomized controlled study of TACE therapy for HCC comparing epi-ADM and CDDP - Comparative study between Cis-TACE and Epi-TACE against hepatocellular carcinoma in combination with Lipiodol

Department of Internal Medicine Keio University School of Medicine0 个研究点目标入组 120 人开始时间: 2006年5月31日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)A patient who has severe complications (however chronic hepatitis and liver cirrhosis are excluded for this criteria). 2)A patient who has active double cancers (besides HCC, the double cancers which can decide the prognosis). 3)A patient who has a medical history of severe hyperesthesia. 4)A patient who is pregnant, a nursing mother or is suspected of being pregnant. 5)A patient who is decided by the principal investigator or a clinical investigator not to be an adequate subject for this study.

研究者

发起方
Department of Internal Medicine Keio University School of Medicine

相似试验